Richard Greene Scott's Insider Trades & SAST Disclosures
Richard Greene Scott's most recent trade in HCW Biologics Inc was a trade of 962 Common Stock done at an average price of $26 . Disclosure was reported to the exchange on May 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard Greene Scott.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCW Biologics Inc | Richard Scott Greene | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 07 May 2025 | 962 | 2,066 | - | 26 | 25,012 | Common Stock |
| HCW Biologics Inc | Richard Scott Greene | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2025 | 481 | 481 | - | - | Common Stock Purchase Warrant | |
| HCW Biologics Inc | Richard Scott Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Richard Greene Scott | Director | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 20 Feb 2024 | 35,714 | 44,125 | - | 1.4 | 50,000 | Common Stock |
| HCW Biologics Inc | Richard Scott Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Richard Scott Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 41,841 | 41,841 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Richard Scott Greene | Director | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 02 Jun 2022 | 4,800 | 8,411 | - | 2.1 | 10,041 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges